Skip to main content
About Croma – Press & Downloads – Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
IMG 2519

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

Croma announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China.

Downloads

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China (136 KB)
Back to top

If you are a healthcare professional (HCP), please log in to see specific information about our products.

Login

I've lost my password

Registration

* fields are required

This website uses cookies

We use cookies to personalise content, to provide social media features and to analyse our traffic. We also share information about your use of our website with our social media and analytics partners, which they may combine with other information you have provided to them or that they have collected from your use of their services. You consent to our cookies if you continue to use our website.